Tag: FDA March 26, 2026 Innovative CAR-T cell therapy receives FDA Breakthrough Therapy designationImmunotherapy for aggressive T-cell cancers developed by WashU Medicine researchers moves to faster approval pathway.News Release July 29, 2025 AI-based breast cancer risk technology receives FDA Breakthrough Device designationSoftware developed at WashU Medicine on accelerated path to approval.News Release August 26, 2020 Washington University develops COVID-19 saliva testTest is faster, simpler than nasal, oral swab tests and enables screening on a massive scale.News Release Posts navigation
